I. S. Hutchinson et al. / Tetrahedron 58 (2002) 3137±3143
3141
then the solvent was removed under vacuum and the residue
was puri®ed by silica gel column chromatography eluted
with acetonitrile to give the product as a white crystalline
turned colourless, the solvent was removed under vacuum
and the residue recrystallised from diethyl ether/pentane to
give white needles, 2.3 g (67%). Mp 94±978C;IR (nujol)
nmax (cm21) 3198, 3058, 1733, 1658, 1445, 1373, 1346,
solid 0.18 g (66%). Mp 106±1088C;IR (nujol) nmax (cm21
)
1
1
3182, 1660, 1435, 1336, 1194, 1129, 1082, 821; H NMR
(CDCl3, 250 MHz) d 6.8 (1H, bs, N±H), 3.65 (1H, dd, J
4.4, 7 Hz, CH±O), 3.6 (2H, q, J7 Hz, OCH2), 3.4 (2H, m,
CH2N), 1.8±2.0 (4H, m, CH2CH2), 1.5 (1H, t, J7 Hz, CH),
1.2 (3H, t, J7 Hz, CH3), 0.7 (1H, t, J4.4 Hz, CH); 13C
NMR (CDCl3, 60 MHz) d 174 (CvO), 67 (OCH2), 64
(OCH), 42 (CH2N), 25 (Cspiro), 24 (CH2), 23 (CH2), 21
(CH2), 15 (CH3);MS m/z (int) 169 (M1, 8), 140 (100),
112 (72), 84 (16), 77 (9), 69 (31), 55 (19), 41 (56);CI-MS
m/z 170 (M11). Anal. found: C 64.11, H 9.03, N 8.32%;
calcd for C9H15NO2: C 63.88, H 8.93, N 8.28%.
1302, 1274, 1170, 1143, 840; H NMR (CDCl3, 250 MHz)
d 7.0 (1H, bs, N±H), 3.8 (3H, s, OCH3), 3.3±3.5 (2H, m,
CH2N), 1.8±2.2 (4H, m, CH2CH2), 2.05 (1H, d, J12.9 Hz,
CH2), 1.9 (1H, d, J12.9 Hz, CH2), 1.5 (3H, s, CH3); 13C
NMR (CDCl3, 60 MHz) d 171 (CvO), 169 (CvO), 98
(Cquat), 98 (Cspiro), 53 (OCH3), 43 (CH2N), 38 (CH2), 33
(CH2), 23 (CH3), 20 (CH2);MS m/z (int) 197 (M228, 31),
165 (46), 137 (100), 109 (24), 79 (16), 67 (20), 41 (20);
CI-MS m/z 198 (M22811). Anal. found: C 53.39, H 6.75,
N 18.46%;calcd for C 10H15N3O3: C 53.33, H 6.66, N 18.67%.
3.3.8. 1,2,7-Triaza-3-methoxycarbonyl-6-oxo-spiro[4.5]-
dec-2-ene 10b. 3-Diazo-piperidin-2-one 2 (1 g, 8 mmol)
was dissolved in methyl acrylate (50 ml) and stirred at
258C for 30 min. The product crystallised out of the reaction
mixture, was ®ltered and washed with chloroform (15 ml) to
afford a white solid, 1.6 g (95%). Mp 160±1618C;IR (nujol)
nmax (cm21) 3212, 3046, 1730, 1644, 1581, 1493, 1342,
3.3.5. 30-Aza-2-oxa-20-oxo-spiro[bicyclo[3.1.0]hexane-
6,l0-cyclohexane] 7. Rhodium(II) acetate (10 mg) was
added to a solution of 3-diazo-piperidin-2-one 2 (0.25 g,
2 mmol) in dihydrofuran (10 ml) and the reaction was
stirred for 12 h at 258C. The solvent was then removed
under vacuum and the residue was passed down a silica
gel column eluted with 5% hexane/THF to afford the
product. This was recrystallised from diethyl ether/pentane
to give a white crystalline solid 0.15 g (45%). Mp 135±
1408C;IR (nujol) nmax (cm21) 3228, 3187, 1651, 1485,
1
1328, 1285, 1261, 1138, 1099, 789; H NMR (DMSO-d6,
250 MHz) d 8.8 (1H, bs, N±H), 7.7 (1H, bs, N±H), 3.7 (3H,
s, OCH3), 3.3 (1H, d, J16.8 Hz, CH2), 3.2 (2H, m, CH2N),
2.65 (1H, d, J16.8 Hz, CH2), 1.6±1.9 (4H, m, CH2CH2);
13C NMR (DMSO-d6, 60 MHz) d 171 (CvO), 163 (CvO),
136 (CvN), 68 (Cspiro), 51 (OCH3), 41 (CH2N), 41 (CH2),
34 (CH2), 19 (CH2);MS m/z (int) 183 (M228, 34), 153 (100),
140 (78), 121 (92), 108 (78), 96 (35), 81 (32), 43 (42);CI-MS
m/z 212 (M11). Anal. found: C 51.00, H 6.24, N 19.72%;
calcd for C9H13N3O3: C 51.18, H 6.20, N 19.89%.
1
1417, 1366, 1335, 1253, 1148, 1122, 1096, 1048, 820; H
NMR (CDCl3, 400 MHz) d 6.0 (1H, bs, N±H), 4.2 (1H, dd,
J8.4, 18 Hz, OCH), 4.1 (1H, d, J6 Hz, CH), 3.9 (1H, dt,
J8.9, 4.4 Hz, OCH), 3.35 (2H, m, CH2N), 2.45 (1H, dd,
J1.24, 7.3 Hz, OCH), 2.25 (1H, m, CH), 1.8±2.0 (3H, m,
CH2, CH), 1.65 (2H, m, CH2); 13C NMR (CDCl3, 60 MHz)
d 172 (CvO), 75 (OCH2), 69 (OCH), 42 (CH2N), 30
(Cspiro), 29 (CH), 24 (CH2), 22 (CH2), 19 (CH2);MS m/z
(int) 167 (M1, 47), 152 (14), 138 (28), 124 (19), 110 (42),
83 (100), 67 (28), 41 (35);CI-MS 168 (M 11). Anal. found:
C 64.52, H 7.93, N 8.14%;calcd for C 9H13NO2: C 64.67, H
7.78, N 8.38%.
3.3.9. 1,2,7-Triaza-3-methylcarbonyl-6-oxo-spiro[4.5]-
dec-2-ene 10c. 3-Diazo-piperidin-2-one 2 (0.11 g, 0.88
mmol) was dissolved in DCM (2 ml) and added, with
stirring, to methyl vinyl ketone (10 ml) at 258C. After
30 min the product crystallised from the reaction mixture,
was ®ltered and washed with methylene chloride (5 ml) to
give white crystals, 0.157 g (91%). Mp 200±2018C;IR
(nujol) nmax (cm21) 3227, 1659, 1634, 1557, 1429, 1385,
3.3.6. 30-Aza-2-oxa-20-oxo-spiro[bicyclo[3.1.0]hexane-
6,10-cylohex-3-ene] 8. Rhodium(II) acetate (15 mg) was
added to a solution of 3-diazo-piperidin-2-one 2 (0.27 g,
2.1 mmol) in furan (25 ml). The reaction mixture was stirred
at 258C for 40 min and then the solvent removed under
vacuum. The residue was puri®ed by silica gel column
chromatography eluted with 5% IPA/MeCN to afford the
product as an orange crystalline solid 0.25 g (60%). Mp
1328C dec;IR (nujol) nmax (cm21) 3183, 3037, 1643,
1594, 1488, 1421, 1332, 1257, 1146, 960; 1H NMR
(CDCl3, 250 MHz) d 6.9 (1H, bs, N±H), 6.4 (1H, d, J
2.5 Hz, OCH), 5.2 (1H, t, J2.6 Hz, CH), 4.8 (1H, d, J
5.7 Hz, OCH), 3.35 (2H, m, CH2N), 2.9 (1H, dd, J5.7,
2.7 Hz, CH), 1.8 (2H, m, CH2), 1.4 (2H, m, CH2); 13C
NMR (CDCl3, 60 MHz) d 174 (CvO), 148 (OCH), 102
(CvCH), 71 (OCH), 42 (CH2N), 36 (CH), 22 (CH2), 17
(CH2), 16 (Cspiro);CI-MS m/z 166 (M11). Anal. found:
C 65.61, H 6.63, N 8.24%;calcd for C 9H11NO2: C 65.43, H
6.71, N 8.48%.
1
1342, 1286, 1256, 1103, 996, 632; H NMR (DMSO-d6,
250 MHz) d 9.1 (1H, bs, N±H), 7.7 (1H, bs, N±H), 3.2
(2H, m, CH2N), 3.18 (1H, d, J16.7 Hz, CH2), 2.55 (1H,
d, J16.7 Hz, CH2), 2.25 (3H, s, CH3), 1.75±1.9 (4H, m,
CH2CH2); 13C NMR (DMSO-d6, 60 MHz) d 193 (CvO),
171 (CvO), 145 (CvN), 68 (Cspiro), 41 (CH2N), 40
(CH2), 32 (CH2), 25 (CH3), 19 (CH2);MS m/z (int) 137
(82), 124 (65), 78 (82), 63 (100), 43 (49);CI-MS m/z 196
(M11). Anal. found: C 55.35, H 6.64, N 21.48%;calcd for
C9H13N3O2: C 55.38, H 6.67, N 21.54%.
3.3.10. 1,2,7-Triaza-3-formyl-6-oxo-spiro[4.5]dec-2-ene
10d. 3-Diazo-piperidin-2-one 2 (0.19 g, 1.52 mmol) was
dissolved in acrolein (10 ml) and stirred for 20 min at
258C. The product crystallised from the reaction mixture,
was ®ltered and washed with chloroform (5 ml) to give a
white crystalline solid, 0.19 g (69%). Mp 178±1828C;IR
(nujol) nmax (cm21) 3164, 1668, 1550, 1491, 1343, 1284,
1246, 1127, 1114, 1003, 850; 1H NMR (DMSO-d6,
250 MHz) d 9.8 (1H, bs, N±H), 9.5 (1H, s, CHO) 7.8
(1H, bs, N±H), 3.2 (2H, m, CH2N), 3.15 (1H, d, J
16.7 Hz, CH2), 2.65 (1H, d, J16.7 Hz, CH2), 1.6±1.9
3.3.7. 1,2,7-Triaza-3-methoxycarbonyl-3-methyl-6-oxo-
spiro[4.5]dec-1-ene 9a. 3-Diazo-piperidin-2-one 2 (1.9 g,
15.2 mmol) was dissolved in methyl methacrylate (20 ml)
and stirred for 4 h at 258C. When the yellow solution had